Abstract
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive
environment
Product coverage
- Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products;
Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies;
Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated
skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans;
Vitamins and dietary supplements; Wound treatments
Executive summary
Sales up in 2006
Value sales of OTC healthcare rose a further 3% in 2006, compared to 2% in
2005. Previous poor performance of cough, cold and allergy remedies began to
turn around in 2006, despite being subject to the continued EDLP (every day
low prices) strategies of leading multiple grocers. Following the abolition of
retail price maintenance (RPM) in 2001, grocery multiples are continuing to
reduce prices on a wide range of OTC products, but rising demand has offset
this negative influence on value sales overall.
Key drivers of growth
Vitamins and dietary supplements, along with medicated skin care and
child-specific products saw particularly high value gains in 2006. In each
case, greater consumer awareness of issues concerning health and wellness
supported sales. In dietary supplements, for example, media coverage espousing
the virtues of fish oils helped stimulate demand. More dynamic growth was
evident in less developed sectors, with OTC statins and emergency
contraception seeing value growth of 38% and 13% respectively.
Consolidation continues
The OTC healthcare market is characterised by a distinct shift towards
consolidation. By far the most significant development during the review
period was the acquisition by Reckitt Benckiser of Boots Healthcare
International, finalised in February 2006 in line with its strategic focus on
its retail pharmacy business. This acquisition has given Reckitt Benckiser
popular UK brands Optrex (eye care), E45 and Clearasil (both medicated skin
care). In addition to this, in June 2006, Pfizer Inc announced its intention
to sell its Consumer Healthcare division to Johnson & Johnson. The deal
creates one of the world' s largest healthcare companies.
Legislation to accelerate reclassification of OTC status
Legislation has proved important in shaping sales across the OTC healthcare
market. In May 2006 the government published its first Better Regulation of
Over the Counter Medicines Initiative (BROMI) report. The recommendations aim
to reduce time spent on administration and divert funds back into speeding up
the reclassification process to enable more products to reach OTC status
sooner.
Multiple grocers fight for OTC share
The major distribution trend in the OTC healthcare market during the review
period was growth in sales through grocery outlets, which has brought chemists
and pharmacies in line to face more direct and fierce competition. The
increasing trend towards purchasing OTC via supermarkets was accelerated by
the abolition of RPM, which meant that chains such Asda, Tesco and Sainsbury' s
slashed the prices of key OTC brands, such as Nurofen, Lemsip and Rennie, and
promoted multiple purchase offers. As a result, newly formed Alliance Boots
lodged a complaint with the Medicines and Healthcare Products Regulatory
Agency (MHRA) about Tesco' s multiple purchase offers on Resolve and Resolve
Extra products. In response, the MHRA agreed with all major retailers to
adhere to the spirit of the 1998 restrictions on pack sizes for analgesics.
Trouble ahead?
Over the forecast period the market for OTC products is predicted to continue
to grow in value, at a CAGR of around 1%. Keener pricing, especially through
major multiples, is likely to continue pressure on prices, especially in what
are rapidly becoming the commodity sectors of cough, cold and allergy
remedies, and analgesics. There could, however, be a bright future in terms of
OTC obesity products, which have already been switched in the Australian
market and, in the current climate of "fat Britain", could well underpin more
substantial growth in the market should they similarly move out of Rx status
in the UK.
Table of Contents
- OTC HEALTHCARE IN THE UNITED KINGDOM : MARKET INSIGHT
- EXECUTIVE SUMMARY
- KEY TRENDS AND DEVELOPMENTS
- Convenience Shoppers
- Children
- Ageing Population
- Self care and self medication
- MARKET INDICATORS
- Table 1 Consumer Expenditure on Health Goods and Medical Services
2001-2006
- Table 2 Life Expectancy at Birth 2001-2006
- MARKET DATA
- Table 3 Sales of OTC Healthcare by Sector: Value 2001-2006
- Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
- Table 5 OTC Healthcare Company Shares by Retail Value 2002-2006
- Table 6 OTC Healthcare Brand Shares by Retail Value 2003-2006
- Table 7 Penetration of Private Label by Sector 2002-2006
- Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis
2001/2006
- Table 9 Sales of OTC Healthcare by Sector and Distribution Format: %
Analysis 2006
- Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
- Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth
2006-2011
- APPENDIX
- OTC Registration and Classification
- Vitamins & Dietary Supplements Registration and
- Classification
- Generics
- Consumer Expenditure on Health Goods and Medical Services
- Table 12 Consumer Expenditure on Health Goods and Medical Services
2001-2006
- DEFINITIONS
- Sources
- Summary 1 Research Sources
- LOCAL COMPANY PROFILES - UNITED KINGDOM
- BAYER PLC - OTC HEALTHCARE - UNITED KINGDOM
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 2 Bayer Plc: Key Facts
- Summary 3 Bayer Plc: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 4 Bayer Plc: Competitive Position 2006
- ERNEST JACKSON LTD - OTC HEALTHCARE - UNITED KINGDOM
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 5 Ernest Jackson Ltd: Key Facts
- COMPANY BACKGROUND
- PRODUCTION
- Summary 6 Ernest Jackson Ltd: Production Statistics 2006
- COMPETITIVE POSITIONING
- Summary 7 Ernest Jackson Ltd: Competitive Position 2006
- GLAXOSMITHKLINE PLC - OTC HEALTHCARE - UNITED
- KINGDOM
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 8 GlaxoSmithKline Plc: Key Facts
- Summary 9 GlaxoSmithKline Plc: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 10 GlaxoSmithKline: Competitive Position 2006
- JOHNSON & JOHNSON MSD - OTC HEALTHCARE - UNITED
- KINGDOM
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 11 Johnson & Johnson MSD: Key Facts
- Summary 12 Johnson & Johnson MSD: Operational Indicators
- COMPANY BACKGROUND
- COMPETITIVE POSITIONING
- Summary 13 Johnson & Johnson MSD: Competitive Position 2006
- NOVARTIS CONSUMER HEALTH UK LTD - OTC HEALTHCARE - UNITED KINGDOM
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 14 Novartis Consumer Health UK Ltd: Key Facts
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 15 Novartis Consumer Health UK Ltd: Competitive Position 2006
- PROCTER & GAMBLE LTD - OTC HEALTHCARE - UNITED
- KINGDOM
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 16 Procter & Gamble UK: Key Facts
- COMPANY BACKGROUND
- COMPETITIVE POSITIONING
- Summary 17 Procter & Gamble UK: Competitive Position 2006
- RECKITT BENCKISER PLC - OTC HEALTHCARE - UNITED KINGDOM
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 18 Reckitt Benckiser UK Ltd: Key Facts
- Summary 19 Reckitt Benckiser UK Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 20 Reckitt Benckiser Plc: Competitive Position 2006
- SEVEN SEAS LTD - OTC HEALTHCARE - UNITED KINGDOM
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 21 Seven Seas Ltd: Key Facts
- Summary 22 Seven Seas Ltd: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- COMPETITIVE POSITIONING
- Summary 23 Seven Seas Ltd: Competitive Position 2006
- SSL INTERNATIONAL PLC - OTC HEALTHCARE - UNITED KINGDOM
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 24 SSL International Plc: Key Facts
- Summary 25 SSL International Plc: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- Summary 26 SSL International Plc: Production Statistics 2006
- COMPETITIVE POSITIONING
- Summary 27 SSL International Plc: Competitive Position 2006
- WYETH CONSUMER HEALTHCARE LTD - OTC HEALTHCARE - UNITED KINGDOM
- STRATEGIC DIRECTION
- KEY FACTS
- Summary 28 Wyeth Consumer Healthcare: Key Facts
- Summary 29 Wyeth Consumer Healthcare: Operational Indicators
- COMPANY BACKGROUND
- PRODUCTION
- Summary 30 Wyeth Consumer Healthcare: Production Statistics 2006
- COMPETITIVE POSITIONING
- Table 13 Summary4 Wyeth Consumer Healthcare: Competitive Position 2006
- ANALGESICS IN THE UNITED KINGDOM
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 14 Sales of Analgesics by Subsector: Value 2001-2006
- Table 15 Sales of Analgesics by Subsector: % Value Growth 2001-2006
- Table 16 Herbal vs Standard Topical Analgesics 2001/2006
- Table 17 Analgesics Company Shares by Retail Value 2002-2006
- Table 18 Analgesics Brand Shares by Retail Value 2003-2006
- Table 19 Forecast Sales of Analgesics by Subsector: Value 2006-2011
- Table 20 Forecast Sales of Analgesics by Subsector: % Value Growth
2006-2011
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE UNITED
- KINGDOM
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: Value 2001-2006
- Table 22 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by
Subsector: % Value Growth 2001-2006
- Table 23 Sales of Decongestants by Type: Value 2001-2006
- Table 24 Sales of Decongestants by Type: % Value Growth 2001-2006
- Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever)
Remedies by Type: Value 2001-2006
- Table 26 Sales of Child-specific Cough, Cold and Allergy (Hay Fever)
Remedies by Type: % Value Growth 2001-2006
- Table 27 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies
2001/2006
- Table 28 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by
Retail Value 2002-2006
- Table 29 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by
Retail Value 2003-2006
- Table 30 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies
by Subsector: Value 2006-2011
- Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies
by Subsector: % Value Growth 2006-2011
- DIGESTIVE REMEDIES IN THE UNITED KINGDOM
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 32 Sales of Digestive Remedies by Subsector: Value 2001-2006
- Table 33 Sales of Digestive Remedies by Subsector: % Value Growth
2001-2006
- Table 34 Herbal vs Standard Digestive Remedies 2001/2006
- Table 35 Digestive Remedies Company Shares by Retail Value 2002-2006
- Table 36 Digestive Remedies Brand Shares by Retail Value 2003-2006
- Table 37 Forecast Sales of Digestive Remedies by Subsector: Value
2006-2011
- Table 38 Forecast Sales of Digestive Remedies by Subsector: % Value
Growth 2006-2011
- MEDICATED SKIN CARE IN THE UNITED KINGDOM
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 39 Sales of Medicated Skin Care by Subsector: Value 2001-2006
- Table 40 Sales of Medicated Skin Care by Subsector: % Value Growth
2001-2006
- Table 41 Herbal vs Standard Medicated Skin Care 2001/2006
- Table 42 Medicated Skin Care Company Shares by Retail Value 2002-2006
- Table 43 Medicated Skin Care Brand Shares by Retail Value 2003-2006
- Table 44 Acne Treatments Brand Shares by Retail Value 2003-2006
- Table 45 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
- Table 46 Forecast Sales of Medicated Skin Care by Subsector: Value
2006-2011
- Table 47 Forecast Sales of Medicated Skin Care by Subsector: % Value
Growth 2006-2011
- VITAMINS AND DIETARY SUPPLEMENTS IN THE UNITED KINGDOM
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR DATA
- Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value
2001-2006
- Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value
Growth 2001-2006
- Table 50 Sales of Vitamins by Type: Value 2001-2006
- Table 51 Sales of Vitamins by Type: % Value Growth 2001-2006
- Table 52 Vitamins and Dietary Supplements Company Shares by Retail Value
2002-2006
- Table 53 Vitamins and Dietary Supplements Brand Shares by Retail Value
2003-2006
- Table 54 Vitamins Brand Shares by Retail Value 2003-2006
- Table 55 Sales of Dietary Supplements by Type: Value 2001-2006
- Table 56 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
- Table 57 Dietary Supplements Brand Shares by Retail Value 2003-2006
- Table 58 Forecast Sales of Vitamins and Dietary Supplements by
Subsector: Value 2006-2011
- Table 59 Forecast Sales of Vitamins and Dietary Supplements
- by Subsector: % Value Growth 2006-2011
- NRT SMOKING CESSATION AIDS IN THE UNITED KINGDOM
- HEADLINES
- TRENDS
- COMPETITIVE LANDSCAPE
- PROSPECTS
- SECTOR INDICATORS
- Table 60 Number of Smokers by Gender 2001-2006 SECTOR DATA
- Table 61 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
- Table 62 Sales of Smoking Cessation Aids by Subsector: % Value Growth
2001-2006
- Table 63 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
- Table 64 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
- Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: Value
2006-2011
- Table 66 Forecast Sales of Smoking Cessation Aids by Subsector: % Value
Growth 2006-2011
- EYE CARE IN THE UNITED KINGDOM
- OVERVIEW
- SECTOR DATA
- Table 67 Sales of Wound Treatments by Subsector: Value 2001-2006
- Table 68 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
- Table 69 Wound Treatments Company Shares by Retail Value 2002-2006
- Table 70 Wound Treatments Brand Shares by Retail Value 2003-2006
- Table 71 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
- Table 72 Forecast Sales of Wound Treatments by Subsector: % Value Growth
2006-2011
- EAR CARE IN THE UNITED KINGDOM
- OVERVIEW
- ADULT MOUTHCARE IN THE UNITED KINGDOM
- OVERVIEW
- CALMING AND SLEEPING PRODUCTS IN THE UNITED KINGDOM
- OVERVIEW
- EMERGENCY CONTRACEPTION IN THE UNITED KINGDOM
- OVERVIEW
- SECTOR DATA
- Table 73 Sales of Emergency Contraception by Subsector: Value 2001-2006
- Table 74 Sales of Emergency Contraception by Subsector: % Value Growth
2001-2006
- Table 75 Forecast Sales of Emergency Contraception by Subsector: Value
2006-2011
- Table 76 Forecast Sales of Emergency Contraception by Subsector: % Value
Growth 2006-2011
- OTC STATINS IN THE UNITED KINGDOM
- OVERVIEWSECTOR DATA
- Table 77 Sales of OTC Statins by Subsector: Value 2004-2006
- Table 78 Sales of OTC Statins by Subsector: % Value Growth 2004-2006
- Table 79 Forecast Sales of OTC Statins by Subsector: Value 2006-2011
- Table 80 Forecast Sales of OTC Statins by Subsector: % Value Growth
2006-2011
- OTC TRIPTANS IN THE UNITED KINGDOM
- OVERVIEW
- SECTOR DATA
- Table 81 Sales of OTC Triptans by Subsector: Value 2006
- Table 82 Forecast Sales of OTC Triptans by Subsector: Value 2006-2011
- Table 83 Forecast Sales of OTC Triptans by Subsector: % Value Growth
2006-2011
医薬品
その他のカテゴリ
FAQ